文献速递颈动脉与弓上血管

重度颈动脉狭窄患者颈动脉内膜切除术后的长期卒中风险

Long-term stroke risk with carotid endarterectomy in patients with severe carotid stenosis.
PubMed 文献 · J Vasc Surg · 2020-07-21

本研究在大型整合医疗系统中回顾2008至2012年因重度(70%-99%)颈动脉狭窄行颈动脉内膜切除术(CEA)的患者,随访至2017年。结果显示无症状组和有症状组30天卒中/死亡粗率分别为0.9%和1.5%,5年同侧卒中风险分别为2.5%和4.0%,围手术期不良事件和长期卒中风险均较低。

要点

  • 无症状组30天卒中/死亡粗率为0.9%,有症状组为1.5%。
  • 5年同侧卒中风险无症状组2.5%,有症状组4.0%。
  • 5年任何卒中/死亡联合终点无症状组28.7%,有症状组31.4%。

核心结论

  • 当代CEA围手术期不良事件和长达5年的长期卒中风险均较低,结果符合共识指南和已发表试验。

研究设计与样本

  • 回顾性队列研究,纳入2008至2012年大型整合医疗系统中 documented 重度(70%-99%)颈动脉狭窄并接受CEA的患者,排除既往同侧干预者,随访至2017年。
  • 共1949例患者(63.2%男性;平均年龄71.3±8.9岁)接受2078次初次CEA,其中无症状1196次(58%),有症状882次(42%)。
  • 平均随访5.5±2.7年。

主要发现

  • 无症状组手术中位时间72.0天(IQR 38.5-198.0),有症状组21.0天(IQR 5.0-55.0),P < .001。
  • 基线他汀使用率无症状组60.5%,有症状组39.9%(P < .001);80%药物持有率依从性分别为19.3%和12.4%(P < .001)。
  • 30天任何卒中/死亡粗率无症状组0.9%,有症状组1.5%。
  • Kaplan-Meier分析5年同侧卒中风险无症状组2.5%,有症状组4.0%;任何卒中/死亡联合终点分别为28.7%和31.4%。
  • 5年未调整累积全因生存率无症状组74.2%,有症状组71.8%。

临床怎么用

  • 对于重度颈动脉狭窄患者,CEA的围手术期和长期卒中风险较低,可用于 informing 关于CEA最佳使用的讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Informed debate regarding the optimal use of carotid endarterectomy (CEA) for stroke risk reduction requires contemporary assessment of both long-term risk and periprocedural risk. In this study, we report long-term stroke and death risk after CEA in a large integrated health care system. METHODS: All patients with documented severe (70%-99%) stenosis from 2008 to 2012 who underwent CEA were identified and stratified by asymptomatic or symptomatic indication. Those with prior ipsilateral interventions were excluded. Patients were followed up through 2017 for the primary outcomes of any stroke/death within 30 days of intervention and long-term ipsilateral ischemic stroke; secondary outcomes were any stroke and overall survival. RESULTS: Overall, 1949 patients (63.2% male; mean age, 71.3 ± 8.9 years) underwent 2078 primary CEAs, 1196 (58%) for asymptomatic stenosis and 882 (42%) for symptomatic stenosis. Mean follow-up was 5.5 ± 2.7 years. Median time to surgery was 72.0 (interquartile range, 38.5-198.0) days for asymptomatic patients and 21.0 (interquartile range, 5.0-55.0) days for symptomatic patients (P < .001). Most of the patients' demographics and characteristics were similar in both groups. Controlled blood pressure rates were similar at the time of CEA. Baseline statin use was seen in 60.5% of the asymptomatic group compared with 39.9% in the symptomatic group (P < .001), and statin adherence by 80% medication possession ratio was 19.3% asymptomatic vs 12.4% symptomatic (P < .001). The crude overall 30-day any stroke/death rates were 0.9% and 1.5% for the asymptomatic group and the symptomatic group, respectively. The 5-year risk of ipsilateral stroke and a combined end point of any stroke/death by Kaplan-Meier survival analysis were 2.5% and 28.7% for the asymptomatic group and 4.0% and 31.4% for the symptomatic group, respectively. Unadjusted cumulative all-cause survival was 74.2% for the asymptomatic group and 71.8% for the symptomatic group at 5 years. CONCLUSIONS: In a contemporary review of CEA, outcomes for either operative indication show low adverse events perioperatively and low long-term stroke risk up to 5 years. These results are well within consensus guidelines and published trial outcomes and should help inform the discussion around optimal CEA use for severe carotid stenosis.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rothenberg KA, Tucker LY, Gologorsky RC, et al. Long-term stroke risk with carotid endarterectomy in patients with severe carotid stenosis. J Vasc Surg. 2020. PMID: 32707387. doi:10.1016/j.jvs.2020.06.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。